As shown in Table 1 and Figures 3A–I, higher expression levels of LIMK1 were observed in male patients (P = 0.004), patients with lymph node metastases (P = 0.022), and patients with high TNM stage (P = 0.048). Here, LIMK1 is linked to metastatic malignant neoplasm in the lymph nodes.